What will the 2023 drug discovery landscape look like?
Drug Discovery World
JANUARY 24, 2023
It’s well-known that 80% of clinical trials fail to meet their enrollment goals, resulting in ballooning R&D costs and delays to market. In many cases, patients can’t afford to wait. Wheeler thinks a continued push into the mainstream for clinical trials, digital trends and an efficiency focus.
97 
Let's personalize your content